Italy Ends Braun IPL Ad Probe After P&G Commitments

Italy's Competition Authority has closed its investigation into Procter & Gamble S.r.l. over advertising claims made for the Braun Skin i-Expert IPL hair removal device, accepting commitments offered by the company instead of proceeding to a finding of unfair commercial practice.

Italy's Competition Authority has closed its investigation into Procter & Gamble S.r.l. over the way the Braun Skin i-Expert IPL hair removal device was advertised, ending the case after the company offered commitments. The outcome, reported by Nasdaq Markets, means the regulator stopped short of a formal ruling on whether the claims amounted to an unfair commercial practice.

Procter & Gamble (PG) shares were little changed on the news, trading at 146.02, up 0.23% on the day as of 13:48 GMT on 25 September 2026, against a previous close of 145.68 and a session range of 145.48 to 146.19. That is a narrower move than the broad market: the S&P 500 tracker (SPY) was at $769.63, up 0.32%, the Dow 30 (DIA) at $514.57, up 0.37%, and the Nasdaq 100 (QQQ) at $744.49, up 0.46%.

What a commitments closure actually means

Italy's Autorità Garante della Concorrenza e del Mercato — the AGCM — supervises both competition and consumer protection, and advertising claims fall squarely inside the second mandate. When it opens a consumer case, the company under scrutiny can propose binding undertakings that address the concerns the regulator raised. If the authority judges those undertakings sufficient, it makes them binding and shuts the file without deciding whether the law was broken and without imposing a fine on the original conduct.

That is what happened here. The investigation into Procter & Gamble S.r.l., the Italian operating entity, concerned advertising claims for the Braun Skin i-Expert IPL device, and it was closed following the company's commitments. The practical effect for the company is certainty: no adverse finding, no headline penalty, and a defined set of obligations it now has to honour. The practical effect for the regulator is speed — a changed advertisement in market beats a contested decision years later.

The trade-off is that a commitments closure produces no precedent. Rival marketers of light-based hair removal devices get no ruling telling them where the line sits, only the inference they can draw from whatever P&G agreed to change.

Why IPL claims attract regulators in the first place

IPL stands for intense pulsed light. The devices fire broad-spectrum light into the skin, where pigment in the hair follicle absorbs the energy and heat disrupts regrowth. Unlike a razor, the pitch is not a clean shave today but a durable reduction in hair over repeated sessions — and that is exactly the kind of claim that invites scrutiny.

Consumer regulators across Europe tend to focus on a handful of recurring questions with this product category. How long does the claimed effect last, and on what evidence? Over what period, and with how many sessions, was the result measured? Does it hold across skin tones and hair colours, or only the subset for which the technology works best? Is a headline figure in an ad supported by a study a consumer can find, and is the qualifying small print legible in the format where the claim appears?

Home beauty devices sit at the awkward junction of cosmetics marketing and quasi-clinical performance promises. They are sold at appliance-level prices on the strength of outcomes consumers cannot verify for weeks. That combination — high ticket, delayed proof, technical language — is a standing invitation for a consumer authority to ask for the substantiation file.

The exposure for a grooming portfolio built on claims

Braun is one of the grooming brands inside Procter & Gamble's portfolio, and grooming is a category where premium pricing is justified almost entirely by performance messaging. A shaver, an epilator or an IPL device is not bought on impulse; it is bought because the packaging and the campaign promise something measurable. Strip out the claim and the price premium over a supermarket alternative is hard to defend.

That is why European advertising enforcement matters more to a company like P&G than the size of any individual penalty suggests. The financial risk in a single national consumer case is rarely material for a group of this scale. The operational risk is the cost of change: reshooting or re-editing campaigns, rewriting packaging copy, retraining retail partners, and aligning the same message across multiple jurisdictions once one regulator has weighed in. Marketing assets are built to run across borders, so a commitment made in Italy tends to travel.

There is also a reputational dimension in a category where the competitive set includes specialist device makers whose entire brand equity rests on efficacy claims. A closure on commitments is a far better outcome for P&G than a finding, precisely because it leaves the Braun name out of a formal breach decision.

What to watch from here

Three things are worth tracking. The first is the substance of the undertakings themselves — whether they touch the advertising copy only, or extend to packaging, point-of-sale material and the evidence base cited for durability claims. The second is whether other European consumer authorities pick up the same product category; national regulators watch each other's consumer files closely, and beauty-tech claims are a live theme.

The third is compliance. Commitments made binding by a competition authority are enforceable on their own terms. A company that fails to deliver what it promised can face a separate, and usually less forgiving, proceeding over the breach of the undertakings rather than the original advertising.

For shareholders, the immediate read is unremarkable — P&G's 0.23% gain on the session tracked slightly behind the main US benchmarks and reflects no visible repricing from the Italian decision. The longer read is about how a consumer-goods group manages claim risk in a portfolio increasingly weighted toward devices and technology-led beauty, where the promise is specific enough to be tested and the regulator is willing to test it.

Key facts

• Regulator: Italy's Competition Authority (AGCM)
• Subject of probe: Advertising claims for the Braun Skin i-Expert IPL hair removal device
• Outcome: Investigation into Procter & Gamble S.r.l. closed following the company's commitments
• PG share price: 146.02, +0.23%, as of 13:48 GMT on 25 Sep 2026

Frequently asked questions

What did Italy's Competition Authority investigate?

The authority examined advertising claims made for the Braun Skin i-Expert IPL hair removal device, a product sold under Procter & Gamble's Braun brand. The case was opened against Procter & Gamble S.r.l., the group's Italian operating entity, and fell under the regulator's consumer protection mandate rather than its competition mandate.

Was Procter & Gamble fined?

No. The investigation was closed following commitments offered by the company. Under the Italian commitments procedure, a company can propose binding undertakings that address the regulator's concerns. If accepted, the authority closes the file without deciding whether the law was breached and without imposing a penalty on the original conduct.

What is an IPL hair removal device?

IPL stands for intense pulsed light. The handheld device emits broad-spectrum light that is absorbed by pigment in the hair follicle, where the resulting heat disrupts regrowth. The claimed benefit is a durable reduction in hair over repeated sessions rather than an immediate shave, which is why efficacy claims draw regulatory attention.

How did P&G shares react?

There was no visible repricing. Procter & Gamble traded at 146.02, up 0.23% on the day as of 13:48 GMT on 25 September 2026, against a previous close of 145.68 and an intraday range of 145.48 to 146.19. That gain trailed the S&P 500 tracker, the Dow 30 tracker and the Nasdaq 100 tracker on the same session.

Do the commitments set a precedent for other advertisers?

Not formally. A commitments closure ends the case without a ruling on whether the advertising broke consumer law, so competitors selling similar light-based hair removal devices get no binding legal standard. They can only infer where the regulator's concerns lay from the substance of the undertakings the company agreed to.

What happens if the commitments are not honoured?

Undertakings accepted and made binding by a competition authority are enforceable in their own right. A company that fails to implement what it promised can face a fresh proceeding for breaching the commitments, which is typically treated more severely than the underlying advertising issue that prompted the original investigation.

Sources

• Italy Closes P&G Probe Over Braun Hair Removal Ads — Nasdaq Markets